SCHEMBL24008152

SCHEMBL24008152

COC1CCC1Cn1cc(C2CC2)cc(N)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24814042 1.00 — —
SCHEMBL25746133 1.00 — —
SCHEMBL24007759 0.85 EPHX2 (0.31) —
SCHEMBL24815030 0.82 — —
SCHEMBL25747930 0.82 — —
SCHEMBL24007992 0.80 SLC18A3 (0.33) —
SCHEMBL24008149 0.79 — —
SCHEMBL24008151 0.79 PDE10A (0.32) —
SCHEMBL24814047 0.79 PDE10A (0.32) —
SCHEMBL26024079 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265075-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. 2023-08-24 — — US disclosed
WO-2021226261-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2021-11-11 — — WO disclosed
Send feedback